Executive Director @ From November 2014 to Present (1 year 1 month) Director @ Oncology clinical development. Early development. IND/CTA filing. Translational medicine. From August 2010 to November 2014 (4 years 4 months) Director, Clinical Development @ Oncology early clinical development. Managing CROs. IND filing. From February 2007 to August 2010 (3 years 7 months) Associate Director
Executive Director @ From November 2014 to Present (1 year 1 month) Director @ Oncology clinical development. Early development. IND/CTA filing. Translational medicine. From August 2010 to November 2014 (4 years 4 months) Director, Clinical Development @ Oncology early clinical development. Managing CROs. IND filing. From February 2007 to August 2010 (3 years 7 months) Associate Director @ Drug safety/pharmcaovigilance.
Project leaders of antibody and small molecule inhibitors of tyrosine kinase receptors and enzymes.
Nonclinical work on cetuximab and ramucirumab. From September 2000 to January 2007 (6 years 5 months)
Harry Miao is skilled in: Oncology Clinical Research, Translational Medicine, Drug Development, Drug Discovery, Biotechnology, Biopharmaceuticals, Biomarkers, Pharmaceutical Industry, Clinical Pharmacology, Molecular & Cellular Biology, Antibodies, CRO, IND, Oncology, Small Molecules
Looking for a different
Harry Miao?
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension